SK ChemicalsLtd Resultados de beneficios anteriores

Pasado controles de criterios 1/6

SK ChemicalsLtd ha aumentado sus beneficios a una tasa media anual de 37.4%, mientras que los beneficios de la industria de Chemicals han experimentado un crecimiento de 12.4% anual. Los ingresos han ido creciendo a una tasa media de 11.6% al año. La rentabilidad financiera de SK ChemicalsLtd es de 1.8%, y sus márgenes netos son de 2.3%.

Información clave

29.3%

Tasa de crecimiento de los beneficios

31.3%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals	13.9%
Tasa de crecimiento de los ingresos	11.5%
Rentabilidad financiera	1.1%
Margen neto	0.9%
Última actualización de beneficios	31 Mar 2024

Actualizaciones de resultados anteriores recientes

We Think That There Are More Issues For SK ChemicalsLtd (KRX:285130) Than Just Sluggish Earnings

Mar 22

Recent updates

We Think That There Are More Issues For SK ChemicalsLtd (KRX:285130) Than Just Sluggish Earnings

Mar 22

Imagine Holding SK ChemicalsLtd (KRX:285130) Shares While The Price Zoomed 499% Higher

Mar 02

An Intrinsic Calculation For SK Chemicals Co.,Ltd. (KRX:285130) Suggests It's 21% Undervalued

Feb 08

SK Chemicals Co.,Ltd. (KRX:285130) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Jan 20

What Type Of Shareholders Own The Most Number of SK Chemicals Co.,Ltd. (KRX:285130) Shares?

Dec 30

When Should You Buy SK Chemicals Co.,Ltd. (KRX:285130)?

Dec 09

Did You Miss SK ChemicalsLtd's (KRX:285130) Whopping 729% Share Price Gain?

Nov 19

Desglose de ingresos y gastos

Cómo gana y gasta dinero SK ChemicalsLtd. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

KOSE:A285130 Ingresos, gastos y beneficios (KRW Millions)
Fecha	Ingresos	Beneficios	Gastos G+A	Gastos de I+D
31 Mar 24	1,765,283	15,929	248,358	131,174
31 Dec 23	1,748,778	35,689	242,019	130,294
30 Sep 23	1,794,436	126,293	251,369	128,788
30 Jun 23	1,645,542	114,243	262,938	120,722
31 Mar 23	1,775,509	170,141	268,028	105,737
31 Dec 22	1,829,191	191,266	272,108	100,220
30 Sep 22	2,123,241	214,870	268,263	95,380
30 Jun 22	2,209,667	237,197	261,208	93,214
31 Mar 22	2,134,811	249,610	243,806	88,657
31 Dec 21	2,089,632	270,006	230,061	85,886
30 Sep 21	1,624,068	219,644	206,824	75,219
30 Jun 21	1,457,229	197,761	193,565	66,415
31 Mar 21	1,319,192	139,871	183,809	63,709
31 Dec 20	1,198,781	89,080	169,155	59,239
30 Sep 20	1,173,655	38,647	165,534	64,198
30 Jun 20	1,105,648	-5,652	152,530	62,720
31 Mar 20	1,112,535	615	152,739	66,423
31 Dec 19	1,112,919	-17,420	155,684	67,287
30 Sep 19	1,155,857	-43,090	162,396	66,938
30 Jun 19	1,248,197	-15,342	161,861	64,872
31 Mar 19	1,306,638	-11,800	160,357	60,004
31 Dec 18	1,367,719	6,028	160,360	60,041
31 Dec 17	1,054,037	-102,431	197,816	57,074
31 Dec 16	1,146,626	11,687	213,585	0
31 Dec 15	1,039,864	119,950	211,509	0
31 Dec 14	1,232,854	-20,128	245,498	0

Ingresos de calidad: A285130 tiene una única gran ganancia de ₩9.4B que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2024.

Margen de beneficios creciente: Los actuales márgenes de beneficio(2.3%) de A285130 son inferiores a los del año pasado (10.5%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: A285130 ha pasado a ser rentable en los últimos 5 años, con un crecimiento de los beneficios de 29.3% al año.

Acelerando crecimiento: A285130 ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: A285130 tuvo un crecimiento negativo de los beneficios (-79.2%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (-14.1%).

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de A285130 (1.8%) se considera baja.

SK ChemicalsLtd Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings released: ₩214 loss per share (vs ₩816 profit in 1Q 2023)

We Think That There Are More Issues For SK ChemicalsLtd (KRX:285130) Than Just Sluggish Earnings

Full year 2023 earnings released: EPS: ₩2,072 (vs ₩9,910 in FY 2022)

Third quarter 2023 earnings released: EPS: ₩2,441 (vs ₩1,815 in 3Q 2022)

First quarter 2023 earnings released: EPS: ₩816 (vs ₩1,881 in 1Q 2022)

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Recent updates

First quarter 2024 earnings released: ₩214 loss per share (vs ₩816 profit in 1Q 2023)

SK chemicals Unveils Blueprint for Circular Recycle™ and Solutions

SK Chemicals, Dongsung Chemical, and Black Yak Collaborate on Commercializing Sustainable Footwear

We Think That There Are More Issues For SK ChemicalsLtd (KRX:285130) Than Just Sluggish Earnings

Full year 2023 earnings released: EPS: ₩2,072 (vs ₩9,910 in FY 2022)

There Is A Reason SK Chemicals Co.,Ltd's (KRX:285130) Price Is Undemanding

Upcoming dividend of ₩1,100 per share at 2.2% yield

Third quarter 2023 earnings released: EPS: ₩2,441 (vs ₩1,815 in 3Q 2022)

Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130).

New minor risk - Profit margin trend

Upcoming dividend of ₩400 per share at 1.5% yield

First quarter 2023 earnings released: EPS: ₩816 (vs ₩1,881 in 1Q 2022)

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to ₩130,000

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Price target increased to ₩333,333

Price target increased to ₩333,333

Upcoming dividend of ₩1,333 per share

Metrica Partners Calls for a Strategic Review at SK Chemicals

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Metrica Partners Sends Letter to SK Chemicals

We Think SK ChemicalsLtd's (KRX:285130) Robust Earnings Are Conservative

Full year 2020 earnings released: EPS ₩621 (vs ₩1,318 loss in FY 2019)

Should You Think About Buying SK Chemicals Co.,Ltd. (KRX:285130) Now?

Investor sentiment deteriorated over the past week

SK Chemicals Co.,Ltd., Annual General Meeting, Mar 31, 2021

Investor sentiment deteriorated over the past week

New 90-day low: ₩347,000

Imagine Holding SK ChemicalsLtd (KRX:285130) Shares While The Price Zoomed 499% Higher

Daejung Chemicals & Metals Co.,Ltd. (KOSDAQ:A120240) acquired 50% in Sk Chemicals Daejung Co,. Ltd from SK Chemicals Co.,Ltd. (KOSE:A285130) for KRW 6 billion.

Price target raised to ₩513,333

An Intrinsic Calculation For SK Chemicals Co.,Ltd. (KRX:285130) Suggests It's 21% Undervalued

New 90-day high: ₩462,500

SK Chemicals Co.,Ltd. (KRX:285130) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Standigm Inc. and K Chemicals Co., Ltd. Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership

What Type Of Shareholders Own The Most Number of SK Chemicals Co.,Ltd. (KRX:285130) Shares?

Upcoming Dividend of ₩450 Per Share

When Should You Buy SK Chemicals Co.,Ltd. (KRX:285130)?

Analysts increase EPS estimates to ₩17,352

Did You Miss SK ChemicalsLtd's (KRX:285130) Whopping 729% Share Price Gain?

Analysts update estimates

New 90-day high: ₩449,500

Kyung-joo Park and other investors acquired 16.03% stake in JSI Co. Ltd. from SK Chemicals Co.,Ltd. (KOSE:A285130) for KRW 0.04 million.

New 90-day high - ₩314,000

Price target raised to ₩183,750

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado